Incyte Corp. (INCY)
107.02
+1.63
(+1.55%)
USD |
NASDAQ |
Jun 11, 10:26
Incyte 1 Year Total Returns (Daily) : 50.41% for June 10, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| June 10, 2026 | 50.41% |
| June 09, 2026 | 47.70% |
| June 08, 2026 | 46.34% |
| June 05, 2026 | 52.26% |
| June 04, 2026 | 50.16% |
| June 03, 2026 | 46.00% |
| June 02, 2026 | 41.23% |
| June 01, 2026 | 46.93% |
| May 29, 2026 | 46.49% |
| May 28, 2026 | 50.16% |
| May 27, 2026 | 48.95% |
| May 26, 2026 | 51.14% |
| May 22, 2026 | 50.61% |
| May 21, 2026 | 50.37% |
| May 20, 2026 | 48.67% |
| May 19, 2026 | 49.82% |
| May 18, 2026 | 50.36% |
| May 15, 2026 | 51.86% |
| May 14, 2026 | 59.63% |
| May 13, 2026 | 62.51% |
| May 12, 2026 | 62.91% |
| May 11, 2026 | 70.09% |
| May 08, 2026 | 65.01% |
| May 07, 2026 | 64.18% |
| May 06, 2026 | 67.51% |
| Date | Value |
|---|---|
| May 05, 2026 | 56.93% |
| May 04, 2026 | 55.35% |
| May 01, 2026 | 56.23% |
| April 30, 2026 | 52.04% |
| April 29, 2026 | 63.99% |
| April 28, 2026 | 64.21% |
| April 27, 2026 | 61.79% |
| April 24, 2026 | 60.51% |
| April 23, 2026 | 64.60% |
| April 22, 2026 | 68.60% |
| April 21, 2026 | 69.40% |
| April 20, 2026 | 66.50% |
| April 17, 2026 | 68.05% |
| April 16, 2026 | 65.11% |
| April 15, 2026 | 66.10% |
| April 14, 2026 | 64.96% |
| April 13, 2026 | 68.01% |
| April 10, 2026 | 74.13% |
| April 09, 2026 | 64.73% |
| April 08, 2026 | 68.32% |
| April 07, 2026 | 55.40% |
| April 06, 2026 | 56.59% |
| April 02, 2026 | 53.91% |
| April 01, 2026 | 54.82% |
| March 31, 2026 | 55.44% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Alnylam Pharmaceuticals, Inc. | -3.72% |
| BioMarin Pharmaceutical, Inc. | -2.28% |
| Vertex Pharmaceuticals, Inc. | -3.50% |
| Mirum Pharmaceuticals, Inc. | 91.92% |
| Biogen, Inc. | 43.36% |